Lebogang Koitsiwe

Lebogang has over 11 years of working experience in the Pharmaceutical Industry, a fully registered Pharmacist with the Botswana Health Professions Council graduated with a Bachelor of Pharmacy from the Latrobe University, Bendigo Australia.
A Pharmacovigilance and Clinical trials Manager with the Botswana Medicines Regulatory Authority (BoMRA), Lebogang has a firm grip in the Drug Regulatory systems, Market dynamics and Pharmaceutical industry, currently responsible for core PV operational functions including Case Management, and Quality and Document Management, managing the operation infrastructure required to oversee all aspects of adverse event collection, processing, and reporting from clinical trials.
Doubling as the President of The Pharmaceutical Society of Botswana, Lebogang is involved in the development of Campaigns that promote health care industry and has gone to develop strategic relations and collaborations with stakeholders within the health industry in Botswana and the SADC region. A member of the Commonwealth Pharmacist Association Council, his role includes but not limited to advocating for collaboration and partnership amongst the Commonwealth Pharmacy Associations. A member of the joint taskforce for the Ministry of Health & Wellness and Business Botswana mandated with developing strategic projects that will see private sector collaboration in public healthcare delivery. Also, member of International Society of Pharmacovigilance
LK as he is affectionally known prides himself with the development of safety exchange agreements with license partners and distributors in support of PV collaborations, a firm believer that accomplishments validate facts you already know while setbacks teach the hard lessons.

Nashwa Nashaat

Yusuf Dawood

Yusuf Dawood is the Country Safety head for SANOFI South Africa. He is also the vice chair of IPASA PV
WorkStream. His areas of expertise include Implementation and management of Pharmacovigilance
system including Patient support programs, Market research programs and Digital projects, Safety
Agreements, Risk Management and case management. He has collaborated on projects such as Global
Reconciliation Working Group, Pharmacovigilance education and internal pharmacovigilance campaigns.
He completed his Master of Pharmacy – with distinction at the University of the Witwatersrand. To
further enhance his management skills, he completed Project Management at the Gordon Institute of
Business sciences. Yusuf strives for excellence with his strategic thinking, simplification of processes and
his creative, innovative and inquisitive charms.

Dr. Winnie Munene

Winnie Munene is the Patient Safety and Pharmacovigilance Manager, Boehringer Ingelheim. She is majorly responsible for English speaking Sub-Sahara African countries. Winnie holds a Bachelor of Pharmacy from University of Nairobi, an MBA in Healthcare Management from Strathmore Business School and higher diploma in Industrial Pharmaceutical Advanced Training from Purdue University/Kilimanjaro School of Pharmacy. She is an Afrika Kommt fellow 2017 having worked at Merck KGaA in their Germany headquarters for an year.
Winnie is a conscientious healthcare professional passionate about healthcare access and social equity all in the sphere of corporate governance and ethical business practice. She has close to 15 years in both management and leadership roles in Pharmacovilance, Quality and Regulatory Affairs with cross-functional management responsibilities for healthcare access programs and projects. She has a good understanding and vast experience of local and global regulations & guidelines.
Winnie is focused on building her expertise in pharmacovigilance and patient safety management, medical and pharmaceutical compliance, new drug registration for go-to market strategies, regulatory, quality assurance management, which are paramount for access to medicines for developing countries.
Her ultimate career goal is to be a thought leader in healthcare access projects and programs, driving and managing projects that are geared towards medicine and medical technologies access & availability while supporting go-to-market strategies.
She is also a mother to a 10 year old strong-willed lovely girl.

Mouhoudine YERIMA

Pharmacovigilance Manager

Togo

Dr. Marian Anwar

Dr. Anwar is a professional business partner, with strong scientific & medical background, brings up 20 years of experience in the pharmaceutical industry.
Dr. Anwar obtained a bachelor’s degree in veterinary medicine and post graduate Microbiology diploma focusing on Immunology, Bacteriology, Virology and Mycology from Cairo University, Egypt.
Dr. Anwar started the career in 2001 as a medical representative in Egypt and then relocated to UAE in 2007, where she held several seniors roles in different top multinational pharmaceutical companies,” Novartis, GSK, Allergan and Abbvie”.
Dr. Anwar accomplished high level of business acumen with diversified roles in Medical affairs, clinical trials and Pharmacovigilance, within diversified geographical areas

Alemayehu Duga

PhArmacoVigilance Africa (PAVIA) coordinator- Eswatini. Alemayehu holds a bachelor’s degree in Pharmacy, a master’s degree in clinical research and currently pursuing his Ph.D. in pharmacovigilance and pharmacoepidemiology at the University of Bordeaux, France.

Diakalia Traore

Poste actuel : Point Focal National de la Pharmacovigilance par décision N°723 MSHP-Centre National d’Appui à la lutte contre la Maladie du 09/09/2015, chargé de :
Recueillir et diffuser les informations sur les effets indésirables des médicaments
Analyser et évaluer le lien entre les produits de santé et les effets indésirables par l’imputabilité ;
Coordonner les activités de notifications au sein des structures et programmes de santé ;
Collecter les notifications d’effets indésirables des produits de santé provenant des professionnels de santé des secteurs public et privé des programmes de santé et de l’industrie pharmaceutique ;
Documenter et archiver les informations sur les effets indésirables des produits de santé dans une banque de santé ;
Faire le suivi et la retro information aux notifications des effets indésirables des produits de santé ;
Répondre aux demandes sur les effets indésirables des médicaments
Assurer les échanges avec le centre international de pharmacovigilance de l’OMS : UMC (Uppsala Monitoring center) ;
Programmer et réaliser des enquêtes de pharmacovigilance ;
Générer les signaux et alertes en matière de pharmacovigilance ;
Participation à la 24 ème session ordinaire du conseil d’administration du Centre National d’ Appui à la lutte contre la Maladie (CNAM) ;
Mission de supervision des activités du deuxième passage de la campagne de Chimio prévention du Paludisme Saisonnier chez les enfants de 3 à 59 mois dans le district sanitaire de Sélingue du 01-07 septembre 2016;
Mission de supervision formative de pharmacovigilance dans les districts sanitaires de Djenne et Bandiagara, Région de Mopti du 20 au 29 Novembre 2016.

Dr Hela Ben Soltana

Dr Eman Gomaa

Eman has a wealth of experience in PV since 2012; with a strong network with decision makers in different health authorities. She held several senior roles in multiple multinational Pharma companies.
She started her PV career in Cairo, in 2012, at the very early beginnings of the Egyptian PV guidelines followed by the Arab GVP implementation in 2015.
She has worked in multiple pharmaceutical companies, from local Egyptian companies to Gilead’s agent in Cairo then joined Allergan as Egypt LSO in March 2016. After one year, she was selected to be the Regional PV Lead for TMEA region in March 2017 and relocated to Dubai in Dec 2017.
She also has a vast experience in delivering trainings to multiple pharmaceutical companies in Egypt on Arab GVP and her trainings were accredited and acknowledged by the Head of Egyptian Pharmaceutical Vigilance Center in Egypt.